Snapshot

The Abridged Review for Small Molecules pathway has been developed by the Agência Nacional de Vigilância Sanitária (ANVISA) of Brazil.

This pathway can be used where Drugs with synthetic active ingredients and semi-synthetic active ingredients, classified as new..

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from EU-EMA United States

Info not found.